Literature DB >> 16585070

Pandemic influenza: using evidence on vaccines and antivirals for clinical decisions and policy making.

A Granados, C Goodman, L Eklund.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16585070     DOI: 10.1183/09031936.06.00017406

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  Long-term respiratory follow-up of H1N1 infection.

Authors:  Paul Zarogoulidis; George Kouliatsis; Nikolaos Papanas; Dionysis Spyratos; Theodoros C Constantinidis; Ioannis Kouroumichakis; Paschalis Steiropoulos; Maria Mabroudi; Dimitris Matthaios; Theodora Kerenidi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis; Efstratios Maltezos
Journal:  Virol J       Date:  2011-06-25       Impact factor: 4.099

2.  Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections.

Authors:  Paul Zarogoulidis; Dimitrios Glaros; Theodoros Kontakiotis; Marios Froudarakis; Ioannis Kioumis; Ioannis Kouroumichakis; Anastasios Tsiotsios; Anastasios Kallianos; Paschalis Steiropoulos; Konstantinos Porpodis; Evagelia Nena; Despoina Papakosta; Aggeliki Rapti; Theodoros C Constantinidis; Theodora Kerenidi; Maria Panopoulou; Georgia Trakada; Nikolaos Courcoutsakis; Evangelia Fouka; Konstantinos Zarogoulidis; Efstratios Maltezos
Journal:  Int J Gen Med       Date:  2012-03-05

Review 3.  WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.

Authors:  Holger J Schünemann; Suzanne R Hill; Meetali Kakad; Richard Bellamy; Timothy M Uyeki; Frederick G Hayden; Yazdan Yazdanpanah; John Beigel; Tawee Chotpitayasunondh; Chris Del Mar; Jeremy Farrar; Tinh Hien Tran; Bülent Ozbay; Norio Sugaya; Keiji Fukuda; Nikki Shindo; Lauren Stockman; Gunn E Vist; Alice Croisier; Azim Nagjdaliyev; Cathy Roth; Gail Thomson; Howard Zucker; Andrew D Oxman
Journal:  Lancet Infect Dis       Date:  2007-01       Impact factor: 25.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.